Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review

SM Nelson, SR Davis, S Kalantaridou… - Human …, 2023 - academic.oup.com
BACKGROUND The early onset of menopause is associated with increased risks of
cardiovascular disease and osteoporosis. As a woman's circulating anti-Müllerian hormone …

Investigation and management of subfertility

L Thurston, A Abbara, WS Dhillo - Journal of clinical pathology, 2019 - jcp.bmj.com
Subfertility affects one in seven couples and is defined as the inability to conceive after 1
year of regular unprotected intercourse. This article describes the initial clinical evaluation …

Is diminished ovarian reserve a risk factor for miscarriage? Results of a systematic review and meta-analysis

A Busnelli, E Somigliana, F Cirillo… - Human Reproduction …, 2021 - academic.oup.com
BACKGROUND Anti-Müllerian hormone (AMH) serum concentration and antral follicle count
(AFC), as measured by transvaginal ultrasonography, accurately reflect the antral follicle …

Clinical applications of serum anti-Müllerian hormone measurements in both males and females: an update

H Xu, M Zhang, H Zhang, K Alpadi, L Wang, R Li… - The Innovation, 2021 - cell.com
Infertility is one of the most common non-communicable diseases, affecting both men and
women equally. Ovarian reserve, the number of primordial follicles in the ovaries is believed …

Comparison of 3 different AMH assays with AMH levels and follicle count in women with polycystic ovary syndrome

LME Moolhuijsen, YV Louwers… - The Journal of …, 2022 - academic.oup.com
Context Anti-Müllerian hormone (AMH) levels strongly correlate with the number of antral
follicles (total follicle count, TFC) in the ovary. In women with polycystic ovary syndrome …

ACOG committee opinion

PP Care - Obstetrics Gynecol, 2019 - journals.lww.com
Perinatal palliative care refers to a coordinated care strategy that comprises options for
obstetric and newborn care that include a focus on maximizing quality of life and comfort for …

Müllerian-inhibiting substance/anti-Müllerian hormone as a predictor of preterm birth in polycystic ovary syndrome

JY Hsu, KE James, CL Bormann… - The Journal of …, 2018 - academic.oup.com
Context There is increasing evidence for Müllerian-inhibiting substance (MIS)/anti-Müllerian
hormone (AMH) physiologic activity in the human uterus, so it is relevant to study how …

Large ovarian endometriomas are associated with high pre-operative anti-Müllerian hormone concentrations

H Roman, I Chanavaz-Lacheray, O Mircea… - Reproductive …, 2021 - Elsevier
Research question Are large ovarian endometriomas associated with high pre-operative
anti-Müllerian hormone (AMH) concentrations? Design Data from 332 women who …

Assessment of circulating anti-müllerian hormone in women using hormonal contraception: a systematic review

SAKS Amer, C James, TK Al-Hussaini… - Journal of Women's …, 2020 - liebertpub.com
Background: The status of ovarian reserve markers during hormonal contraception (HC)
remains uncertain with conflicting literature data. The purpose of this study was to assess the …

The stability of the anti-Müllerian hormone in serum and plasma samples under various preanalytical conditions

R Vrzáková, V Šimánek, O Topolčan, V Vurm, D Slouka… - Diagnostics, 2023 - mdpi.com
The anti-Müllerian hormone (AMH) is a glycoprotein that plays an important role in prenatal
sex differentiation. It is used as a biomarker in polycystic ovary syndrome (PCOS) …